Premium
Molecular analysis of norovirus in specimens from children enrolled in a 1982‐1986 study in Belém, Brazil: A community‐based longitudinal study
Author(s) -
Siqueira Jones Anderson Monteiro,
Sousa Júnior Edivaldo Costa,
Linhares Alexandre da Costa,
Gabbay Yvone Benchimol
Publication year - 2017
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.24817
Subject(s) - norovirus , virology , feces , genotyping , capsid , biology , genotype , polymerase chain reaction , asymptomatic , gene , virus , medicine , genetics , microbiology and biotechnology
Fecal specimens were collected during a longitudinal, community‐based study in the city of Belém, North Brazil, that was conducted over 3 years (October 1982 to March 1986), in which 20 children were included from birth to 3 years of age. A total of 229 fecal samples were screened by real time RT‐PCR targeting the junction region (ORF 1/2) of the norovirus (NoV) genome. NoV‐positive samples were subjected to PCR and sequencing of the viral polymerase (ORF1) and viral protein 1 (VP1) genes (ORF2). The junction region was also sequenced to assess for recombination when ORF1 and ORF2 genotyping results were dissimilar. Samples classified as GII.P4/GII.4 were further characterized by sequencing the P2 subdomain of the viral capsid to determine possible alterations. An overall positivity of 16.1% (37/229) was observed, including GI (16.2%‐6/37) and GII (83.8%‐31/37) genogroups. Cases of NoV reinfection in at least 2‐month intervals were observed, and 12 children developed at least one case of asymptomatic NoV infection. In total, 48.6% (18/37) NoV‐positive samples were subjected to nucleotide sequencing analysis targeting the following polymerase genes: GI.P3 ( n = 1), GII.Pa ( n = 1), GII.Pc ( n = 1), GII.P4 ( n = 5), GII.P6 ( n = 5), GII.P7 ( n = 3), GII.P12 ( n = 1), and GII.P22 ( n = 1). For the VP1 gene, characterization was performed in 14 (77.8%) samples: GI.3 ( n = 1), GII.2 ( n = 1), GII.4 ( n = 4), GII.6 ( n = 4), GII.7 ( n = 1), GII.12 ( n = 1), GII.14 ( n = 1), and GII.23 ( n = 1). Recombination events were confirmed in three cases (GII.P12/GII.2, GII.P7/GII.14, and GII.Pa/GII.12), and four samples genotyped as GII.P4/GII.4 were analyzed to identify variants. None had contemporary counterparts. Three children developed consecutive NoV infections by different genotypes. The present report documents the importance of NoV as a cause of childhood infection during a longitudinal study conducted more than 30 years ago.